Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma

Zhao Y, Liu X, He Q, Yu Y, Xu L, Sun C, Liu G, Wang L, Ma J

Blood and Lymphatic Cancer: Targets and Therapy 2025, 15:203-216

Published Date: 6 December 2025